Use of sevelamer hydrochloride and calcium carbonate in the control of hyperphosphatemia in patients in hemodialysis
DOI:
https://doi.org/10.5585/conssaude.v8i3.1734Keywords:
Carbonato de cálcio, Doença renal crônica classe V, Hiperparatireoidismo secundário, Sevelamer.Abstract
To evaluate the effectiveness of sevelamer and calcium carbonate as phosphate binder. METHODS: We selected 31 patients (55±14 years) who underwent haemodyalisis (HD) 3 times / week 4 h / session, which were raised test results in zero time and end time, split into 3 groups: GI: in use of calcium carbonate; GII: in use of sevelamer; GIII: without the use of phosphate binders. The GII showed a trend for higher number of extra sessions of dialysis and longer HD versus GI. The level of calcium tended to be different in GII vs GI. There was a trend for higher initial level of phosphorus GII vs GIII. Sevelamer has great therapeutic value and is of paramount importance to CKD V patients on dialysis hypercalcemic. There is evidence that in the long term, the use of sevelamer bring benefits in reducing the morbidity associated with haemodialysis.Downloads
Downloads
Published
2009-10-29
How to Cite
1.
de Deus RB, Malagutti W, Ferraz RRN. Use of sevelamer hydrochloride and calcium carbonate in the control of hyperphosphatemia in patients in hemodialysis. Cons. Saúde [Internet]. 2009 Oct. 29 [cited 2025 May 23];8(3):477-83. Available from: https://periodicos.uninove.br/saude/article/view/1734
Issue
Section
Artigos
License
Copyright (c) 2009 ConScientiae Saúde

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Views
- Abstract 1766
- PDF (Português (Brasil)) 504